Drugplain

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial

Hydroquinone, Homosalate, Octisalate, Zinc Oxide · KIT · Obagi Cosmeceuticals LLC

No Recall History
Plain English

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial is a kit containing hydroquinone, homosalate, octisalate, zinc oxide. Manufactured by Obagi Cosmeceuticals LLC.

Key Facts

Brand Name
Obagi Nu-Derm System Normal-Oily Skin Transformation Trial
Generic Name
Hydroquinone, Homosalate, Octisalate, Zinc Oxide
NDC Code (Product)
62032-914
Manufacturer
Obagi Cosmeceuticals LLC
Dosage Form
KIT
Marketing Status
Marketing Start
12/02/2019

Recall History

No Recall History

Frequently Asked Questions

What is Obagi Nu-Derm System Normal-Oily Skin Transformation Trial used for?

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial contains Hydroquinone, Homosalate, Octisalate, Zinc Oxide. It is a kit taken as directed. Consult your doctor for specific uses.

Is Obagi Nu-Derm System Normal-Oily Skin Transformation Trial a controlled substance?

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial is not classified as a controlled substance by the DEA.

What is the generic name for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial?

The generic name for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial is Hydroquinone, Homosalate, Octisalate, Zinc Oxide. There are 5 other brand versions of Hydroquinone, Homosalate, Octisalate, Zinc Oxide.

What is the NDC code for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial ?

The NDC (National Drug Code) for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial is 62032-914, listed by Obagi Cosmeceuticals LLC.

Product NDC

62032-914

Package NDC

62032-914-01

Other Hydroquinone, Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)